Observations placeholder
Meropenem
Identifier
019514
Type of Spiritual Experience
Background
A description of the experience
Meropenem is an ultra-broad-spectrum injectable antibiotic used to treat a wide variety of infections. It is a β-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem.
It gained US FDA approval in July 1996. It penetrates well into many tissues and body fluids, including cerebrospinal fluid, bile, heart valve, lung, and peritoneal fluid.
The most common adverse effects are diarrhea (4.8%), nausea and vomiting (3.6%), injection-site inflammation (2.4%), headache (2.3%), rash (1.9%), and thrombophlebitis (0.9%) Many of these adverse effects were observed in the setting of severely ill individuals already taking many medications including vancomycin. One study showed Clostridium difficile-associated diarrhea happened in 3.6% of the patients on meropenem. Several cases of severe hypokalemia have been reported.
On Jan, 06, 2017 8,079 people reported to have side effects when taking Meropenem. Among them, 33 people (0.41%) have Hallucination
Time on Meropenem when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Meropenem :
| Female | Male | |
| Hallucination | 15.00% | 85.00% |
On Dec, 17, 2015: 4,978 people reported to have side effects when taking Meropenem. Among them, 144 people (2.89%) have Death.
Time on Meropenem when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 96.36% | 3.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Meropenem :
| Female | Male | |
| Death | 38.62% | 61.38% |